PRESS RELEASE published on 10/14/2024 at 07:30, 1 year 9 months ago Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Nicox and Soleus sign $16.5 million royalty and equity financing agreement, reducing debt burden and financing into Q3 2025. Topline results expected in Q3 2025 for NCX 470 Denali Phase 3 trial Equity Financing Nicox NCX 470 Soleus Royalty
BRIEF published on 09/18/2024 at 07:35, 1 year 10 months ago Nicox Announces Approval of ZERVIATE in China China Ophthalmology Nicox ZERVIATE Ocumension
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 10 months ago Nicox Announces Approval of ZERVIATE in China Nicox announces approval of ZERVIATE in China by partner Ocumension Therapeutics for ocular itching, adding royalty revenue stream. Launch expected to boost market penetration China Approval Nicox ZERVIATE Ocular Itching
BRIEF published on 09/04/2024 at 07:35, 1 year 10 months ago Nicox Appoints Christine Placet as Director; Michele Garufi Retires from Board of Directors Board Of Directors Ophthalmology Christine Placet Nicox Michele Garufi
PRESS RELEASE published on 09/04/2024 at 07:30, 1 year 10 months ago Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board Nicox appoints Christine Placet to Board of Directors as Michele Garufi steps down after over 25 years. Entire Nicox Board renewed for strategic direction support Board Of Directors Biotech Industry Christine Placet Nicox Michele Garufi
BRIEF published on 07/19/2024 at 07:35, 2 years ago Nicox: Participation in upcoming conferences Conférences 2024 Investments Ophthalmology Nicox
PRESS RELEASE published on 07/19/2024 at 07:30, 2 years ago Nicox announces attendance at upcoming conferences Nicox announces attendance at upcoming international conferences, including H.C. Wainwright 4th Annual Ophthalmology Virtual Conference and AAO 2024 Clinical Development International Conférences Ophthalmology Nicox
BRIEF published on 07/18/2024 at 07:35, 2 years ago Nicox Provides Second Quarter 2024 Update Q2 2024 Financial Update Ophthalmology Nicox NCX 470
PRESS RELEASE published on 07/18/2024 at 07:30, 2 years ago Nicox Provides Second Quarter 2024 Update Nicox reports €1.6M revenue & €7.8M cash for Q2 2024, extending funds until Feb 2025. Focus on NCX 470 development & Denali trial progress. New Board members appointed Revenue Cash Position Nicox NCX 470 Denali Trial
BRIEF published on 07/16/2024 at 07:35, 2 years ago Nicox appoints Damian Marron Chairman of the Board of Directors Board Of Directors Ophthalmology Nicox Marc Le Bozec Damian Brown
Published on 08/01/2026 at 01:20, 1 day 11 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 11 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 11 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 13 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/02/2026 at 08:15, 4 hours 7 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 19 hours 46 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 16 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 17 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 1 day 15 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 17 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 17 hours ago Covivio Hotels - 2026 Half-year financial report
